The authors treated 12 schizophrenic patients who had overt
hallucinatory symptoms with intravenously administered naloxone
hydrochloride, a narcotic antagonist purported to have antihallucinatory
properties. They found no evidence of the effectiveness of naloxone in
preventing hallucinations over that of placebo when administered in a
randomized, double-blind fashion.Abstract Teaser